Location: Los Angeles, CA
CIK: 0001389933 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value: $291M (98.6% shares, 1.4% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| STXS | STEREOTAXIS INC | 13,680,554 | $72.37M | 24.8% | $0.97 | +311.2% | COM NEW | 85916J409 |
| PRQR | PROQR THERAPEUTICS N V | 1,114,000 | $11.04M | 3.8% | $7.50 | +3.9% | SHS EURO | N71542109 |
| ATRC | ATRICURE INC | 318,729 | $10.36M | 3.6% | $13.70 | +107.8% | COM | 04963C209 |
| — | ARQULE INC | 497,762 | $9.935M | 3.4% | $5.73 | — | COM | 04269E107 |
| — | BLUEPRINT MEDICINES CORP | 123,218 | $9.871M | 3.4% | $51.64 | — | COM | 09627Y109 |
| GLPG | GALAPAGOS NV | 47,000 | $9.721M | 3.3% | $75.63 | — | SPON ADR | 36315X101 |
| FATE | FATE THERAPEUTICS INC | 470,000 | $9.198M | 3.2% | $19.02 | -16.5% | COM | 31189P102 |
| — | SAGE THERAPEUTICS INC | 124,806 | $9.01M | 3.1% | $158.36 | — | COM | 78667J108 |
| DXCM | DEXCOM INC | 36,338 | $7.949M | 2.7% | $17.91 | +164.8% | COM | 252131107 |
| IBB | ISHARES TR NASDAQ BIOTECH | 64,900 | $7.821M | 2.7% | $120.65 | — | ETF | 464287556 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 61,008 | $6.558M | 2.3% | $58.26 | +79.7% | COM | 64125C109 |
| — | AERIE PHARMACEUTICALS INC | 267,839 | $6.474M | 2.2% | $32.97 | — | COM | 00771V108 |
| — | ZOGENIX INC | 106,749 | $5.565M | 1.9% | $35.09 | — | COM NEW | 98978L204 |
| — | CARA THERAPEUTICS INC | 328,533 | $5.293M | 1.8% | $18.36 | — | COM | 140755109 |
| AKBA | AKEBIA THERAPEUTICS INC | 770,538 | $4.87M | 1.7% | $11.62 | -59.1% | COM | 00972D105 |
| — | LUMINEX CORP | 204,091 | $4.727M | 1.6% | $20.87 | — | COM | 55027E102 |
| — | ARENA PHARMACEUTICALS INC | 98,942 | $4.494M | 1.5% | $40.00 | — | COM NEW | 040047607 |
| CYTK | CYTOKINETICS INC | 418,727 | $4.443M | 1.5% | $7.84 | +30.9% | COM NEW | 23282W605 |
| — | BIOHAVEN PHARMACEUTICALS HOLD | 74,700 | $4.067M | 1.4% | $38.72 | — | COM | G11196105 |
| ASND | ASCENDIS PHARMA A S | 28,100 | $3.909M | 1.3% | $56.66 | — | SPONSORED ADR | 04351P101 |
| — | MENLO THERAPEUTICS INC | 797,565 | $3.701M | 1.3% | $5.94 | — | COM | 586858102 |
| — | RADIUS HEALTH INC | 4,000,000 | $3.395M | 1.2% | $1.00 | — | NOTE 3.000% 9/0 | 750469AA6 |
| XENE | XENON PHARMACEUTICALS INC | 248,854 | $3.262M | 1.1% | $7.72 | +36.3% | COM | 98420N105 |
| — | AFFIMED NV | 1,133,559 | $3.106M | 1.1% | $2.74 | — | COM | N01045108 |
| — | ACHILLION PHARMACEUTICALS | 438,884 | $2.646M | 0.9% | $5.03 | — | COM | 00448Q201 |
| — | DICERNA PHARMACEUTICALS INC | 118,314 | $2.606M | 0.9% | $12.56 | — | COM | 253031108 |
| — | BIOTELEMETRY INC | 55,300 | $2.56M | 0.9% | $29.11 | — | COM | 090672106 |
| ALEC | ALECTOR INC | 145,000 | $2.498M | 0.9% | $18.19 | -6.5% | COM | 014442107 |
| KURA | KURA ONCOLOGY INC | 173,475 | $2.385M | 0.8% | $15.64 | -5.3% | COM | 50127T109 |
| — | CARDIOVASCULAR SYSTEMS INC | 46,200 | $2.245M | 0.8% | $31.77 | — | COM | 141619106 |
| — | BLUEBIRD BIO INC | 25,500 | $2.238M | 0.8% | $136.36 | — | COM | 09609G100 |
| — | PHASEBIO PHARMACEUTICALS INC | 360,542 | $2.203M | 0.8% | $7.12 | — | COM | 717224109 |
| ARAY | ACCURAY INC | 674,300 | $1.902M | 0.7% | $3.88 | -28.5% | COM | 004397105 |
| — | TURNING POINT THERAPEUTICS I | 30,408 | $1.894M | 0.7% | $37.60 | — | COM | 90041T108 |
| ARCT | ARCTURUS THERAPEUTICS HLDG I | 173,914 | $1.89M | 0.6% | $10.76 | -2.7% | COM | 03969T109 |
| — | OTONOMY INC | 469,135 | $1.797M | 0.6% | $3.83 | — | COM | 68906L105 |
| STIM | NEURONETICS INC | 395,772 | $1.777M | 0.6% | $7.48 | -16.9% | COM | 64131A105 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 514,051 | $1.773M | 0.6% | $5.49 | -54.2% | COM | 09058V103 |
| — | KADMON HOLDINGS INC | 374,423 | $1.696M | 0.6% | $2.65 | — | COM | 48283N106 |
| VKTX | VIKING THERAPEUTICS INC | 209,200 | $1.678M | 0.6% | $11.47 | -36.4% | COM | 92686J106 |
| — | EPIZYME INC | 68,000 | $1.673M | 0.6% | $12.55 | — | COM | 29428V104 |
| MGNX | MACROGENICS INC | 150,000 | $1.632M | 0.6% | $16.30 | -39.3% | COM | 556099109 |
| — | APPLIED GENETIC TECHNOL CORP | 359,190 | $1.624M | 0.6% | $12.15 | — | COM | 03820J100 |
| — | CORBUS PHARMACEUTICALS HLDGS | 297,300 | $1.623M | 0.6% | $6.39 | — | COM | 21833P103 |
| INGN | INOGEN INC | 23,000 | $1.572M | 0.5% | $97.05 | -35.4% | COM | 45780L104 |
| — | ELOXX PHARMACEUTICALS INC | 205,825 | $1.515M | 0.5% | $9.97 | — | COM | 29014R103 |
| ARDX | ARDELYX INC | 199,850 | $1.5M | 0.5% | $5.98 | +1.6% | COM | 039697107 |
| — | TRANSLATE BIO INC | 179,845 | $1.464M | 0.5% | $11.24 | — | COM | 89374L104 |
| — | NATUS MEDICAL INC | 42,900 | $1.415M | 0.5% | $33.36 | — | COM | 639050103 |
| JNJ | JOHNSON AND JOHNSON | 9,400 | $1.371M | 0.5% | $59.66 | +91.3% | COM | 478160104 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 100,000 | $1.32M | 0.5% | $16.10 | — | SPON ADS | 05280R100 |
| — | SYNLOGIC INC | 500,731 | $1.292M | 0.4% | $2.33 | — | COM | 87166L100 |
| APLS | APELLIS PHARMACEUTICALS INC | 40,657 | $1.245M | 0.4% | $27.52 | +0.6% | COM | 03753U106 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 13,600 | $1.239M | 0.4% | $125.02 | -22.4% | COM | 558868105 |
| — | PREVAIL THERAPEUTICS INC | 75,000 | $1.187M | 0.4% | $13.20 | — | COM | 74140Y101 |
| — | NEXTCURE INC | 20,000 | $1.127M | 0.4% | $56.35 | — | COM | 65343E108 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 542,564 | $1.123M | 0.4% | $5.22 | -54.5% | COM NEW | 372427401 |
| — | SCYNEXIS INC | 1,207,413 | $1.099M | 0.4% | $2.06 | — | COM | 811292101 |
| ARGX | ARGENX SE | 6,071 | $975K | 0.3% | $63.62 | — | SPONSORED ADR | 04016X101 |
| — | MILLENDO THERAPEUTICS INC | 129,525 | $873K | 0.3% | $6.74 | — | COM | 60040X103 |
| CTMX | CYTOMX THERAPEUTICS INC | 100,000 | $831K | 0.3% | $9.86 | -31.6% | COM | 23284F105 |
| — | EXICURE INC | 275,000 | $787K | 0.3% | $2.86 | — | COM | 30205M101 |
| — | ASSEMBLY BIOSCIENCES INC | 35,573 | $728K | 0.2% | $25.68 | — | COM | 045396108 |
| INSM | INSMED INC | 30,000 | $716K | 0.2% | $27.86 | -27.0% | COM PAR $.01 | 457669307 |
| — | GAMIDA CELL LTD | 148,781 | $640K | 0.2% | $5.08 | — | SHS | M47364100 |
| — | MORPHIC HOLDING INC | 37,000 | $635K | 0.2% | $17.16 | — | COM | 61775R105 |
| — | MERSANA THERAPEUTICS INC | 108,463 | $621K | 0.2% | $3.60 | — | COM | 59045L106 |
| — | DEXCOM INC | 250,000 | $556K | 0.2% | $1.15 | — | NOTE 0.750% 5/1 | 252131AF4 |
| MASI | MASIMO CORPORATION | 3,000 | $474K | 0.2% | $43.65 | +244.4% | COM | 574795100 |
| — | GRITSTONE ONCOLOGY INC | 50,000 | $449K | 0.2% | $11.14 | — | COM | 39868T105 |
| — | RADIUS HEALTH INC | 22,000 | $444K | 0.2% | $21.68 | — | COM NEW | 750469207 |
| KALV | KALVISTA PHARMACEUTICALS INC | 24,725 | $440K | 0.2% | $15.77 | -17.3% | COM | 483497103 |
| — | SUTRO BIOPHARMA INC | 40,000 | $440K | 0.2% | $13.14 | — | COM | 869367102 |
| — | ZAFGEN INC | 305,500 | $339K | 0.1% | $4.13 | — | COM | 98885E103 |
| — | RIGEL PHARMACEUTICALS INC | 157,700 | $337K | 0.1% | $3.40 | — | COM NEW | 766559603 |
| — | ADVAXIS INC | 350,000 | $300K | 0.1% | $0.27 | — | COM NEW | 007624307 |
| WVE | WAVE LIFE SCIENCES LTD | 36,960 | $296K | 0.1% | $39.36 | -37.7% | SHS | Y95308105 |
| — | ASLAN PHARMACEUTICALS LTD | 117,682 | $239K | 0.1% | $2.03 | — | ADS | 04522R101 |
| URGN | UROGEN PHARMA LTD | 3,987 | $133K | 0.0% | $51.86 | -47.4% | COM | M96088105 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 95,000 | $85,000 | 0.0% | $1.03 | -19.2% | COM | 53566P109 |
| — | EVELO BIOSCIENCES INC | 10,726 | $44,000 | 0.0% | $6.10 | — | COM | 299734103 |